Scarica l'app Stockscreener
10.43
2.61%
-0.28
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EVH Giù?
Forum
Previsione
Precedente Chiudi:
$10.71
Aprire:
$10.69
Volume 24 ore:
5.20M
Relative Volume:
2.26
Capitalizzazione di mercato:
$1.20B
Reddito:
$2.35B
Utile/perdita netta:
$-74.42M
Rapporto P/E:
-11.10
EPS:
-0.94
Flusso di cassa netto:
$150.93M
1 W Prestazione:
+4.09%
1M Prestazione:
+2.56%
6M Prestazione:
-62.90%
1 anno Prestazione:
-65.16%
Intervallo 1D:
$10.34
$11.03
Intervallo di 1 settimana:
$9.75
$11.03
Portata 52W:
$9.45
$35.00
Evolent Health Inc Stock (EVH) Company Profile
Nome
Evolent Health Inc
Settore
Industria
Telefono
571-389-6000
Indirizzo
800 NORTH GLEBE RD, SUITE 500, ARLINGTON
Confronta EVH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
10.43 | 1.20B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
225.79 | 36.66B | 2.66B | 665.91M | 1.08B | 4.05 |
|
DOCS
Doximity Inc
|
72.37 | 13.58B | 516.85M | 174.11M | 217.38M | 0.87 |
|
SOLV
Solventum Corp
|
73.02 | 12.61B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
TEM
Tempus Ai Inc
|
68.09 | 10.72B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
108.60 | 9.41B | 1.15B | 96.70M | -161.99M | 1.09 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-03 | Reiterato | BTIG Research | Buy |
| 2024-11-08 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Aggiornamento | Truist | Hold → Buy |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-01 | Iniziato | Oppenheimer | Outperform |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-10-16 | Iniziato | UBS | Buy |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2022-11-01 | Iniziato | Truist | Hold |
| 2022-07-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2021-11-18 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Ripresa | JP Morgan | Neutral |
| 2021-01-07 | Iniziato | BTIG Research | Buy |
| 2020-07-06 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Downgrade | Goldman | Buy → Neutral |
| 2020-06-02 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Ripresa | Leerink Partners | Outperform |
| 2018-06-04 | Iniziato | Piper Jaffray | Overweight |
| 2018-04-24 | Ripresa | JP Morgan | Neutral |
| 2017-09-20 | Iniziato | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Iniziato | Robert W. Baird | Outperform |
| 2017-03-14 | Iniziato | Oppenheimer | Outperform |
| 2017-01-13 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Ripresa | JP Morgan | Overweight |
| 2016-08-05 | Reiterato | FBR Capital | Outperform |
| 2016-07-26 | Iniziato | Jefferies | Buy |
| 2016-07-13 | Reiterato | FBR Capital | Outperform |
| 2016-03-29 | Iniziato | FBR Capital | Outperform |
| 2016-01-06 | Iniziato | Canaccord Genuity | Buy |
| 2015-06-30 | Iniziato | Goldman | Buy |
| 2015-06-30 | Iniziato | JP Morgan | Overweight |
| 2015-06-30 | Iniziato | Leerink Partners | Outperform |
| 2015-06-30 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Evolent Health Inc Borsa (EVH) Ultime notizie
Analysts Have Lowered Expectations For Evolent Health, Inc. (NYSE:EVH) After Its Latest Results - Simply Wall St
Evolent Health Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Evolent Health’s AI Strategy: Navigating Risks and Challenges Amidst Technological Advancements - TipRanks
Evolent Health Inc. Reports Mixed Earnings Results - TipRanks
Piper Sandler cuts Evolent Health target to $16, maintains overweight By Investing.com - Investing.com Canada
Evolent Health, Inc. SEC 10-K Report - TradingView
Evolent Health outlines 15%-18% growth target for 2025 amid oncology trend challenges - MSN
Evolent Health Inc (EVH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Oncology ... - Yahoo Finance
Evolent Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Evolent Health Reports Growth and Strategic Gains - TipRanks
Evolent Announces Fourth Quarter and Full Year 2024 Results - The Malaysian Reserve
Evolent Health: Q4 Earnings Snapshot - mySA
Evolent Health Inc earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets By Stock Story - Investing.com Canada
Evolent Health (EVH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Evolent Health Inc Reports Q4 EPS of -$0.27, Narrowly Beating Es - GuruFocus.com
Evolent Health (NYSE:EVH) Misses Q4 Sales Targets - Yahoo Finance
Evolent Health Swings to Q4 Adjusted Loss, Sales Rise; Revenue Guidance Set; Shares Drop After Hours - Marketscreener.com
Evolent Health (EVH) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
Evolent Health (EVH) Q4 2024 Earnings Call Transcript - MSN
Evolent Health misses Q4 estimates, shares drop on weak guidance - Investing.com India
Evolent Health misses Q4 estimates, shares drop on weak guidance By Investing.com - Investing.com UK
Evolent Health, Inc. Reports Q4 and Full Year 2024 Financial Results - TradingView
Earnings Flash (EVH) Evolent Health Posts Q4 Revenue $646.5M, vs. FactSet Est of $651.3M - Marketscreener.com
Evolent Health Inc (EVH) Q4 2024 Earnings Report Preview: What T - GuruFocus.com
Evolent Health Inc (EVH) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Evolent Health (NYSE:EVH) Is Doing The Right Things To Multiply Its Share Price - Yahoo Canada Finance
Evolent Health's SWOT analysis: stock faces challenges amid growth potential By Investing.com - Investing.com Nigeria
Evolent Health's SWOT analysis: stock faces challenges amid growth potential - Investing.com
Canaccord cuts Evolent Health target to $16, maintains Buy - MSN
Evolent Health (EVH) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
(EVH) Technical Data - Stock Traders Daily
Evolent Health, Inc. (NYSE:EVH) Shares Purchased by Entropy Technologies LP - MarketBeat
Evolent Health (NYSE:EVH) Given Market Outperform Rating at JMP Securities - MarketBeat
Needham & Company LLC Reaffirms Buy Rating for Evolent Health (NYSE:EVH) - MarketBeat
Evolent Health (NYSE:EVH) Hits New 1-Year LowTime to Sell? - MarketBeat
Evolent Health stock hits 52-week low at $9.55 - MSN
Earnings Preview: Evolent Health (EVH) Q4 Earnings Expected to Decline - Yahoo Finance
Evolent Health stock hits 52-week low at $9.55 By Investing.com - Investing.com Canada
Evolent Health Stock: A Deep Dive Into Analyst Perspectives (15 Ratings) - Benzinga
Evolent Health (NYSE:EVH) Hits New 52-Week LowWhat's Next? - MarketBeat
Further weakness as Evolent Health (NYSE:EVH) drops 7.5% this week, taking one-year losses to 68% - Simply Wall St
Evolent Health gains as activist Engaged Capital reaches cooperation agreement - MSN
William Blair Lowers Earnings Estimates for Evolent Health - MarketBeat
How the (EVH) price action is used to our Advantage - Stock Traders Daily
Evolent Health appoints new chair and independent director By Investing.com - Investing.com South Africa
Evolent Health Inc Azioni (EVH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
9.30%
2.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):